-
Je něco špatně v tomto záznamu ?
Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review
B. İlhan, T. Erdoğan, E. Topinková, G. Bahat, EuGMS Task and Finish Group on FRIDs
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
- MeSH
- alfa blokátory škodlivé účinky MeSH
- antagonisté muskarinových receptorů škodlivé účinky MeSH
- hyperaktivní močový měchýř * farmakoterapie komplikace MeSH
- hyperplazie prostaty * farmakoterapie komplikace MeSH
- lidé MeSH
- senioři MeSH
- symptomy dolních močových cest * komplikace farmakoterapie MeSH
- úrazy pádem prevence a kontrola MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
PURPOSE: We aimed to outline the existing information and the underlying mechanisms of risk of falls associated with the use of urinary antimuscarinics for overactive bladder (OAB) or alpha-blockers for benign prostatic hyperplasia (BPH) in older adults. In addition, we aimed to provide assistance to clinicians in decision-making about (de-)prescribing these drugs in older adults. METHODOLOGY: Based on a literature search in PubMed and Google Scholar, we reviewed the literature, and identified additional relevant articles from reference lists, with an emphasis on the most commonly prescribed drugs in OAB and BPH in older patients. We discussed the use of bladder antimuscarinics and alpha-blockers, their potential side effects related to falls, and the deprescribing of these drugs in older adults. RESULTS: Urinary urgency or incontinence and lower urinary tract symptoms due to untreated OAB and BPH contribute to fall risk. On the other hand, the use of bladder antimuscarinics and alpha-blockers is also related to fall risk. They contribute to (or cause) falling through dizziness, somnolence, visual impairment, and orthostatic hypotension while they differ in their side-effect profiles regarding these problems. Falls are common and can cause a remarkable amount of morbidity and mortality. Thus, preventive measures should be taken to lower the risk. If the clinical condition allows, withdrawal of bladder antimuscarinics and alpha-blockers is recommended in fall-prone older adults. There are practical resources and algorithms that guide and assist clinicians in deprescribing these drug groups. CONCLUSIONS: The decision to prescribe or deprescribe these treatments in patients at high risk of falls should be individualized. In addition to explicit tools that are helpful for clinical decision-making in (de-)prescribing these drugs, STOPPFall (a recently developed expert-based decision aid specifically aiming to prevent falls) is present to assist prescribers in attaining decisions.
Geriatrics Clinic Tekirdağ Dr Ismail Fehmi Cumalıoglu City Hospital Tekirdağ Turkey
Internal Medicine and Geriatrics Clinic Liv Hospital Vadi Istanbul Istanbul Turkey
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016736
- 003
- CZ-PrNML
- 005
- 20231026105605.0
- 007
- ta
- 008
- 231013s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s41999-023-00798-7 $2 doi
- 035 __
- $a (PubMed)37245173
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a İlhan, Birkan $u Internal Medicine, and Geriatrics Clinic, Liv Hospital Vadi Istanbul, Istanbul, Turkey
- 245 10
- $a Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review / $c B. İlhan, T. Erdoğan, E. Topinková, G. Bahat, EuGMS Task and Finish Group on FRIDs
- 520 9_
- $a PURPOSE: We aimed to outline the existing information and the underlying mechanisms of risk of falls associated with the use of urinary antimuscarinics for overactive bladder (OAB) or alpha-blockers for benign prostatic hyperplasia (BPH) in older adults. In addition, we aimed to provide assistance to clinicians in decision-making about (de-)prescribing these drugs in older adults. METHODOLOGY: Based on a literature search in PubMed and Google Scholar, we reviewed the literature, and identified additional relevant articles from reference lists, with an emphasis on the most commonly prescribed drugs in OAB and BPH in older patients. We discussed the use of bladder antimuscarinics and alpha-blockers, their potential side effects related to falls, and the deprescribing of these drugs in older adults. RESULTS: Urinary urgency or incontinence and lower urinary tract symptoms due to untreated OAB and BPH contribute to fall risk. On the other hand, the use of bladder antimuscarinics and alpha-blockers is also related to fall risk. They contribute to (or cause) falling through dizziness, somnolence, visual impairment, and orthostatic hypotension while they differ in their side-effect profiles regarding these problems. Falls are common and can cause a remarkable amount of morbidity and mortality. Thus, preventive measures should be taken to lower the risk. If the clinical condition allows, withdrawal of bladder antimuscarinics and alpha-blockers is recommended in fall-prone older adults. There are practical resources and algorithms that guide and assist clinicians in deprescribing these drug groups. CONCLUSIONS: The decision to prescribe or deprescribe these treatments in patients at high risk of falls should be individualized. In addition to explicit tools that are helpful for clinical decision-making in (de-)prescribing these drugs, STOPPFall (a recently developed expert-based decision aid specifically aiming to prevent falls) is present to assist prescribers in attaining decisions.
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antagonisté muskarinových receptorů $x škodlivé účinky $7 D018727
- 650 12
- $a hyperplazie prostaty $x farmakoterapie $x komplikace $7 D011470
- 650 _2
- $a úrazy pádem $x prevence a kontrola $7 D000058
- 650 12
- $a hyperaktivní močový měchýř $x farmakoterapie $x komplikace $7 D053201
- 650 12
- $a symptomy dolních močových cest $x komplikace $x farmakoterapie $7 D059411
- 650 _2
- $a alfa blokátory $x škodlivé účinky $7 D000317
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Erdoğan, Tuğba $u Geriatrics Clinic, Tekirdağ Dr. Ismail Fehmi Cumalıoglu City Hospital, Tekirdağ, Turkey
- 700 1_
- $a Topinková, Eva $u Department of Geriatric Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague and Faculty of Health and Social Sciences, University of South Bohemia, České Budejovice, Czechia
- 700 1_
- $a Bahat, Gülistan $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Istanbul, Turkey. gbahatozturk@yahoo.com $1 https://orcid.org/0000000153439795
- 710 2_
- $a EuGMS Task and Finish Group on FRIDs
- 773 0_
- $w MED00166753 $t European geriatric medicine $x 1878-7649 $g Roč. 14, č. 4 (2023), s. 733-746
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37245173 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105559 $b ABA008
- 999 __
- $a ok $b bmc $g 2000325 $s 1203098
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 14 $c 4 $d 733-746 $e 20230528 $i 1878-7649 $m European geriatric medicine $n Eur Geriatr Med $x MED00166753
- LZP __
- $a Pubmed-20231013